Together we shape the future of HPB

Innovation to transform HPB outcomes

Challenges of managing symptomatic pancreatic pseudocysts

Picture of patient holding stomach in pain​

Approximately 5% to 16% of patients with acute pancreatitis and 20% to 40% of patients with chronic pancreatitis will develop pancreatic pseudocysts (PP).1 While some patients are asymptomatic, others experience severe pain, bloating and poor digestion and must receive treatment.​

​Symptomatic pancreatic pseudocysts may be treated surgically, percutaneously, or endoscopically. However, surgery is associated with high rates of morbidity (7%-37%) and mortality (6%). Percutaneous drainage also provides limited treatment benefit as recurrence rates are high and fistulas may form.2​

​Purpose-built pseudocyst drainage tools can help healthcare professionals provide cost-effective therapies to improve patient health outcomes. Previously, endoscopic management of pancreatic pseudocysts has been difficult as the available technologies were not designed or intended for this purpose.​

Enabling effcient and effective treatment procedures​

At Boston Scientific, we work tirelessly to deliver innovative solutions that help you offer the best possible treatment experience to your patients.

Pancreatic Fluid  Collection/Walled off necrosis drainage

The AXIOS™ System is intended to overcome the limitations of other drainage options.​

hot axios stent
Learn more about the Hot AXIOS™ Stent

Connect with us:

representing downloading a document or information

Product catalogue​

Download the product catalogue
representing email correspondence

Get updates

Get updates​

References

1. Aghdassi et al, “Pancreatic pseudocysts – when and how to treat?” HPB 2006; 8: 432-441.​

2. Shah et al, “Safety and Efficacy of Endoscopic Ultrasound-Guided Drainage of Pancreatic Fluid Collections with Lumen-Apposing Covered Self-Expanding Metal Stents.” Gastroenterol and Hepatol Oct 5, 2014; 13: 747-752.

CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device or at www.IFU-BSCI.com. Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. This material not intended for use in France.​​All images owned by Boston Scientific.​